Buscar resultados de ensayos clínicos
Leukemia, Myeloid, Chronic-Phase - 25 Studies Found
Estado | Estudiar |
Withdrawn |
Nombre del estudio: Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms Condición: Leukemia, Myeloid, Chronic-Phase Fecha: 2012-07-24 |
Terminated |
Nombre del estudio: Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) Condición: Leukemia, Myeloid, Chronic Phase Fecha: 2005-07-27 Intervenciones: Drug: Imatinib mesylate Imatinib is packaged in bottles as 100mg and 400mg tablets |
Completed |
Nombre del estudio: Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey Condición: Leukemia, Myeloid, Chronic-Phase (CML-CP) Fecha: 2010-08-24 Intervenciones: Drug: Imatinib Drug being observed but not provided |
Active, not recruiting |
Nombre del estudio: Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy Condición: Chronic Phase CML Fecha: 2011-10-14 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib Condición: Chronic Phase Chronic Myeloid Leukemia Fecha: 2012-05-04 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML Condición: Leukemia, Chronic Myeloid Fecha: 2016-11-22 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib Condición: Leukemia Fecha: 2008-10-21 Intervenciones: Drug: Dasatinib Other Name: Sprycel (BMS-354825) |
Active, not recruiting |
Nombre del estudio: Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients Condición: Chronic Phase Chronic Myeloid Leukemia Fecha: 2012-10-03 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) Condición: Leukemia, Myelogenous, Chronic Fecha: 2005-08-11 Intervenciones: Drug: Nilotinib 400 mg orally twice daily Other Name |
Terminated |
Nombre del estudio: Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib Condición: Leukemia, Myeloid, Chronic Fecha: 2006-05-01 Intervenciones:
|